Nice & Green has contributed to the success of Affluent Medical’s capital increase, which raised over EUR 13,7 million

Nice & Green, the Swiss investment firm, has contributed to the successful capital increase of Affluent Medical, a French MedTech company that is developing innovative solutions for the treatment of heart and vascular diseases. This transaction extends Affluent Medical’s cash flow through November 2023.

This operation is intended to (i) Commencement and potential completion of patient recruitment for the Minerva study to evaluate Epygon, (ii) Finalization of patient recruitment for the Optimise II clinical study, and preparation for industrialization of the Kalios medical device, (iii) Initiation of the Dry study to evaluate Artus and (iv) Continuation of efforts to repay the financial debt of the Group.

Bertrand Schmitt, Managing Partner of Nice & Green said: “We are proud to have participated in the capital increase of Affluent Medical, and believe that this operation will help to drive the development of cutting-edge medical technologies that have the potential to make a significant impact in healthcare.”

About Nice & Green

Nice & Green is a leading privately held Swiss funding firm, active in the European market providing smart funding solutions to listed Micro-, Small- and Mid-Cap companies supporting their growth as partners. Find out more at

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the ambition of becoming a global leader in the treatment of heart and vascular diseases, which are the world’s leading cause of mortality, and urinary incontinence which currently affects one in four adults. Affluent Medical develops next-generation, mini-invasive, innovative implants to restore critical physiological functions in these areas. The four major technologies developed by the company are currently in preclinical and clinical studies. KaliosTM is set to be the first medical device to be marketed in Europe. For more information:

Contact Information

Morgane Henchoz
MarCom Specialist
+41 22 361 36 97